MERIDIAN BIOSCIENCE INC's ticker is VIVO and the CUSIP is 589584101. A total of 161 filers reported holding MERIDIAN BIOSCIENCE INC in Q2 2014. The put-call ratio across all filers is 4.00 and the average weighting 0.1%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2017 | $10,095,000 | -9.6% | 705,936 | -0.5% | 0.16% | -12.8% |
| Q2 2017 | $11,173,000 | -13.5% | 709,363 | -24.2% | 0.18% | -10.4% |
| Q1 2017 | $12,911,000 | -64.6% | 935,590 | -54.5% | 0.20% | -30.4% |
| Q4 2016 | $36,424,000 | +72.9% | 2,057,906 | +88.4% | 0.29% | -16.7% |
| Q3 2016 | $21,071,000 | -1.2% | 1,092,335 | -0.1% | 0.35% | -4.7% |
| Q2 2016 | $21,331,000 | -5.8% | 1,093,860 | -0.4% | 0.36% | -7.6% |
| Q1 2016 | $22,645,000 | +28.6% | 1,098,713 | +28.1% | 0.39% | +20.5% |
| Q4 2015 | $17,604,000 | -29.5% | 857,873 | -29.1% | 0.33% | -9.9% |
| Q2 2014 | $24,961,000 | -4.1% | 1,209,346 | +1.2% | 0.36% | -6.2% |
| Q1 2014 | $26,031,000 | -19.4% | 1,194,599 | -1.8% | 0.39% | -17.8% |
| Q4 2013 | $32,278,000 | +5.1% | 1,216,653 | -6.4% | 0.47% | +0.2% |
| Q3 2013 | $30,712,000 | +8.0% | 1,299,668 | -1.7% | 0.47% | +2.4% |
| Q2 2013 | $28,430,000 | – | 1,322,322 | – | 0.46% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| SYQUANT CAPITAL SAS | 134,804 | $4,477 | 11.01% |
| Vazirani Asset Management LLC | 115,774 | $3,845 | 6.51% |
| FIFTH LANE CAPITAL, LP | 185,914 | $6,174,204 | 5.56% |
| NEXPOINT ASSET MANAGEMENT, L.P. | 1,939,075 | $64,396,681 | 5.01% |
| Crystalline Management Inc. | 244,453 | $8,118,284 | 4.08% |
| FNY Investment Advisers, LLC | 51,000 | $1,693 | 2.36% |
| HAVENS ADVISORS LLC | 26,800 | $890,028 | 2.26% |
| Euclidean Technologies Management, LLC | 62,995 | $2,092,064 | 1.99% |
| Sand Grove Capital Management LLP | 537,060 | $17,836 | 1.70% |
| Crabel Capital Management, LLC | 120,337 | $3,996 | 1.45% |